NetScientific Announces Preliminary Biomarker Study Results for Head, Neck Cancer
By Anthony O. Goriainoff NetScientific said that its portfolio company PDS Biotechnology announced data from the phase 2 clinical trial evaluating the safety...
Source: marketwatch.com